TrialCancer science2006

Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma.

Hideaki Shimada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.